Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mike Carusi
AddedApr 2, 2024
UpdatedMay 31, 2026
Mike Carusi

Mike Carusi

Board Member, Glumetrics

Crunchbase

Mike Carusi's Career

Glumetrics
Glumetrics

Irvine, CA, US

Board Member· Board
Gynesonics
Gynesonics

Redwood City, CA, US

Board Member· Board
Second Genome
Second Genome

South San Francisco, CA, US

Board Member· Board
Nuvaira
Nuvaira

Minneapolis, MN, US

Board Member· Board
EndoGastric Solutions
EndoGastric Solutions

Redmond, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mike Carusi's Career

Glumetrics
Glumetrics
Series A$68.2M302005Irvine, CA, US
Board Member· Board

Leadership at Glumetrics

William H. MarkleWilliam H. MarkleFounder
Gynesonics
Gynesonics
Public$401.8M1392005Redwood City, CA, US
Board Member· Board

Leadership at Gynesonics

Susan StimsonSusan StimsonBoard Member
Bali MuralidharBali MuralidharBoard Member
Doug FisherDoug FisherBoard Member
Tom RodgersTom RodgersBoard Member
Jessica GrossmanJessica GrossmanFounder
Karen TalmadgeKaren TalmadgeBoard Member

Similar to Gynesonics

Minerva SurgicalMinerva SurgicalSanta Clara, CA, USMedical Devicesest. 2008Minerva SurgicalSanta Clara, CA, US · est. 2008

US-based Minerva offers a comprehensive suite of devices for minimally invasive treatment of Abnormal Uterine Bleeding.

Public · $173.9M189
Mirabilis MedicaMirabilis MedicaBothell, WA, USMedical Devicesest. 2006Mirabilis MedicaBothell, WA, US · est. 2006

Mirabilis Medica designs therapeutic ultrasound devices for uterine fibroids treatment in the US.

Angel · $29.1M8
FemasysFemasysSuwanee, GA, USMedical Devicesest. 2004FemasysSuwanee, GA, US · est. 2004

Femasys: Innovating women's healthcare through R&D and manufacturing of medical devices.

Public · $70.8M34
PharmasonicsPharmasonicsSunnyvale, CA, USMedical Devicesest. 1995PharmasonicsSunnyvale, CA, US · est. 1995

Innovative medical tech company in Sunnyvale, CA.

Series A · $6.1M30
Second Genome
Second Genome
Acquired$62.5M02009South San Francisco, CA, US
Board Member· Board

Leadership at Second Genome

Corey GoodmanCorey GoodmanBoard Member
Brad MargusBrad MargusBoard Member
Jill CarrollJill CarrollBoard Member
Jason LettmannJason LettmannBoard Member
Janet WarringtonJanet WarringtonCo-Founder
Todd DeSantisTodd DeSantisCo-Founder
Nuvaira
Nuvaira
Series B$204M462008Minneapolis, MN, US
Board Member· Board

Leadership at Nuvaira

Steve DimmerSteve DimmerCo-Founder
Hank PlainHank PlainBoard Member
Martin MayseMartin MayseCo-Founder
Alexander SchmitzAlexander SchmitzBoard Member
Tim HerbertTim HerbertBoard Member
Dennis WahrDennis WahrCEO

Similar to Nuvaira

NuvetaNuvetaPortola Valley, CA, USMedical Technologyest. 2009NuvetaPortola Valley, CA, US · est. 2009

US-based Nuveta Inc. provides innovative medical technology services.

Pre-Seed · $800k30
Aerwave MedicalAerwave MedicalNaples, FL, USMedical Devicesest. 2020Aerwave MedicalNaples, FL, US · est. 2020

Aerwave Medical: Pioneering non-drug COPD and asthma treatments since 2020, based in New York.

Seed · $8M7
NeVapNeVapSan Jose, CA, USMedical Devicesest. 2014NeVapSan Jose, CA, US · est. 2014

NeVap innovates cost-effective medical devices, like our FDA-approved tube, to combat Ventilator Associated Pneumonia.

Seed · $1M11
NirvaMedNirvaMedMinneapolis, MN, USMedical Devicesest. 2019NirvaMedMinneapolis, MN, US · est. 2019

NirvaMed: Innovating heart attack treatment with unique, non-invasive solutions for myocardial infarctions.

Series A · $5.1M5
EndoGastric Solutions
EndoGastric Solutions
Series B$380.2M922003Redmond, WA, US
Board Member· Board

Leadership at EndoGastric Solutions

Arda MinocherhomjeeArda MinocherhomjeeBoard Member
Darin HammersDarin HammersBoard Member
Alejandro SanchezAlejandro SanchezBoard Member
Joe MandatoJoe MandatoBoard Member
Brent AhrensBrent AhrensBoard Member
Jordan S. DavisJordan S. DavisBoard Member

Similar to EndoGastric Solutions

EndoSoundEndoSoundPortland, OR, USMedical Devicesest. 2016EndoSoundPortland, OR, US · est. 2016

EndoSound: Pioneering technology for advanced endoscopic ultrasound solutions.

Angel · $410.8k12
Max EndoscopyMax EndoscopyMacedonia, OH, USMedical Devicesest. 2007Max EndoscopyMacedonia, OH, US · est. 2007

MAX Endoscopy: Innovating cost-effective endoscopic devices for enhanced GI treatments.

Seed · $385k6
EvoEndoEvoEndoEnglewood, CO, USMedical Devicesest. 2017EvoEndoEnglewood, CO, US · est. 2017

EvoEndo: Innovating unsedated endoscopic procedures with sterile, single-use systems.

Series B · $19M16
EnVision EndoscopyEnVision EndoscopyLowell, MA, USMedical Devicesest. 2018EnVision EndoscopyLowell, MA, US · est. 2018

EnVision Endoscopy: Innovative medical device provider for endoscopic surgeries.

Pre-Seed · $1.8M8

Mike Carusi's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Mike Carusi

Leighton ReadLeighton ReadBoard Member · Cambrios TechnologiesAdam GridleyAdam GridleyBoard Member · LifeSproutStephen BlochStephen BlochBoard Member · LiquidiaDan JanneyDan JanneyBoard Member · Krystal BiotechHarrison BainsHarrison BainsBoard Member · BG Medicine